Cerevel Therapeutics Holdings, Inc.
Cerevel Therapeutics Holdings, Inc. (CERE) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
cere · stock forecast · 16 analysts (3M) · FMP · updated Aug 27, 2025
Analyst Rating & Consensus
Based on 16 Wall Street analysts in the past 3 months
Hold
16 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$40.00
Consensus
$33.50
-25.5% upside
Low
$27.00
Median: $33.5 · Last Close: $44.96
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$33.50
-25.5% upside
High Target
$40
-11.0%
Low Target
$27
-39.9%
Current Price
$44.96
as of today
Based on analyst price targets, the CERE stock price prediction for the next 12 months ranges from $27 to $40. The consensus CERE price forecast of $33.50 implies -25.5% upside from the current price of $44.96.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $46.16 | ↑ 2.67% |
1-day model range: $46.02–$46.3. Peak: $46.3 (+2.67%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $55 | +23.1% |
| 2028 | $63 | +40.1% |
| 2029 | $68 | +51.8% |
| 2030 | $72 | +59.4% |
| 2031 | — | +64.1% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CERE · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-02-16 | Mizuho | Maintains | Neutral→Neutral |
| 2023-12-28 | JP Morgan | Maintains | Neutral→Neutral |
| 2023-12-22 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2023-12-08 | TD Cowen | Downgrade ↓ | Outperform→Market Perform |
| 2023-12-07 | Piper Sandler | Downgrade ↓ | Overweight→Neutral |
| 2023-12-07 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2023-12-07 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2023-11-02 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2023-08-07 | Mizuho | Maintains | Neutral→Neutral |
| 2023-08-06 | Mizuho | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Cerevel Therapeutics Holdings, Inc. (CERE) stock. Of the recent 78 rating actions, 2 were upgrades and 13 were downgrades. 16 analysts currently cover CERE.
Analyst Recommendation Trends
CERE analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$14M
EPS This Year
$-2.91
EPS Next Year
$-3.15
↑ 8.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast CERE EPS of $-2.91 for the current fiscal year, based on estimates from 4 analysts. The CERE revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CERE stock forecast is supported by two independent data sources: analyst consensus ratings from 16 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CERE price target is $33.50 (-25.5% upside), with an analyst consensus of Hold.
The CERE short-term stock prediction for tomorrow is $46.16 (+2.67%). The CERE stock price prediction for 2027 estimates an average of $55. The CERE stock prediction for 2030 projects a range of $69–$74.
Cerevel Therapeutics Holdings, Inc. trades on NASDAQ under the ticker CERE. The CERE stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 38% of covering analysts.
Frequently asked questions
CERE forecast · 8 questionsAccording to 16 Wall Street analysts, the average 12-month CERE price target is $33.50, with a high forecast of $40.00 and a low of $27.00. The median price target is shown in the chart above when available. This implies -25.5% potential upside from the current price of $44.96.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.